Clinical Trials in Baltimore

Showing 20461-20480 of 23,476 trials

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

NCT01556711

The objectives of the study are to document device performance with respect to the primary and secondary endpoints.

BrainScope Company, Inc.816 participantsStarted Aug 2012

Hartford, Connecticut, United States • Baltimore, Maryland, United States • Baltimore, Maryland, United States +8 more locations

COMPLETEDPhase 3< 1 mile

A Study of Aripiprazole in Patients With Major Depressive Disorder

NCT00105196

The purpose of this 14 week, randomized, double-blind, placebo controlled study is to assess the safety and efficacy of aripiprazole to placebo as adjunctive treatment to an assigned open-label marketed antidepressant therapy (ADT) in patients with Major Depressive Disorder who demonstrate an incomplete response to a prospective eight week trial of the same assigned open-label marketed antidepressant therapy.

Major Depressive Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.349 participantsStarted Mar 2005

Birmingham, Alabama, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +31 more locations

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

A Study of Aripiprazole in Patients With Major Depressive Disorder

Find Trials by Condition in Baltimore

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

Rheumatoid Arthritis: Comparison of Active Therapies in Patients With Active Disease Despite Methotrexate Therapy

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine

Mindfulness Meditation in Bone Marrow Transplantation

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression